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Plasmodium falciparum, the causative agent of the 
most virulent form of human malaria, has deservingly 
held the candidature of being one of the most studied 
human pathogens. Here we attempt an overview of the 
studies probing one of the important aspects of DNA 
metabolism, that is, DNA replication in this parasite, 
focusing on the relatively well-characterized core  
components of chromosomal DNA replication in the 
asexual intra-erythrocytic stage. 
 
Keywords: DNA replication, origin recognition com-
plex, Plasmodium falciparum, schizogony. 
Introduction 
PROTOZOAN parasite of genus Plasmodium, the causative 
agent of malaria, is responsible for an estimated 350–500 
million clinical malarial episodes, most of which are caused 
by infection with Plasmodium falciparum and Plasmo-
dium vivax. The former causes more than one million 
deaths each year, mainly in young children in synergy 
with other infections and illnesses. Approximately 60% 
of world’s cases of malaria, including close to 75% of 
global P. falciparum malaria cases occur in sub-Saharan 
Africa1. Malaria has been a problem in India for centu-
ries. Details of this disease can be found even in the an-
cient Indian medical literature like the Charaka Samhita. 
The annual incidence of malaria was estimated at around 
75 million cases in 1953, with about 8 lakh deaths annu-
ally. To combat this menace, the Government of India 
launched the National Malaria Control Programme in 
April 1953. The programme proved highly successful2 
and within five years, the incidence dropped to 2 million. 
It was then that a series of setbacks was witnessed lead-
ing to a sharp rise in the number of reported cases. Cur-
rently, India accounts for two-thirds of all confirmed 
malaria cases reported from the South East Asia region, 
with Odisha, Jharkhand, West Bengal, Madhya Pradesh 
and Chhattisgarh contributing to the bulk (60%) of  
malaria3. Most of the malaria attributable mortality is 
reported from Odisha and other forested areas inhabited 
by ethnic tribes in the country4. 
 Globally, P. falciparum malaria has become a matter of 
concern as it is increasingly showing resistance to the 
commonly used drugs like quinine, chloroquine, sul-
phadoxine, etc. It has become an urgent necessity to iden-
tify new drug targets for therapeutic intervention. DNA 
replication is a key biological process essential for both 
parasite survival and multiplication. Identification of a 
pathway or protein(s) of this important aspect of DNA 
metabolism that could be blocked or targeted offers a lot 
of scope and hope to combat this deadly parasitic disease. 
Plasmodium life cycle 
Of the human malaria species, P. falciparum is medically 
the most important and it is responsible for most of the 
mortality and morbidity associated with the disease. The 
life cycle of P. falciparum is complex, involving inva-
sive, trophic and replicative forms in two different hosts – 
human and female Anopheles mosquito. Transmission  
between mosquitoes and humans involves a spectacular  
series of morphological transformations (Figure 1). The 
asexual stage begins with transmission of motile sporo-
zoites into the blood stream of the human host during mos-
quito feeding. The sporozoites enter the hepatocytes 
where they multiply and then differentiate to generate 
numerous merozoites. Upon release, the merozoites pro-
ceed to invade the red blood cells (RBCs) of the host to 
initiate the blood stage of the infection. This is also the 
stage most successfully adapted into laboratory culture 
conditions. The intra-erythrocytic (IE) parasite matures 
through the ring, trophozoite and schizont stages, eventu-
ally bursting to release 16 or more daughter merozoites5,6. 
 DNA replication, one of the fundamental biological 
processes, may be the key to these life-cycle changes. It 
appears that in spite of having multiple distinct develop-
mental stages in the complex malaria life cycle where 
DNA replication occurs (Figure 1), the general features 
of eukaryotic DNA replication processes may be con-
served in the parasite. 
 Cell biology and enzymology of the parasite DNA rep-
lication is not well understood, primarily because the cell 
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Figure 1. An illustrative diagram showing an overall Plasmodium falciparum life cycle in female anophiline mosquito and human hosts, depict-
ing various stages and their approximate duration. Inverted forks (1–4) indicate the probable stages where DNA replication takes place. (The above 
figure is a modified form of the image available at http://www.dpd.cdc.gov/dpdx/HTML/Malaria.htm.) 
 
 
cycle differs in several ways from that of better-
understood models such as yeasts and mammalian cells7. 
However, for any organism, accurate and timely duplica-
tion of the chromosomes is indispensable. Failure to com-
pletely copy the genome has the potential to result in 
catastrophic genomic instability.  
Chromosomal replication 
Timing of replication  
The overall organization of cell division in Plasmodium 
is unique compared to that observed in model organisms 
because DNA replicates more than once per cell cycle at 
several points of its life cycle8. DNA replication and cell-
cycle studies in human malarial parasite P. falciparum in 
combination with those conducted in murine malarial 
parasite, P. berghei in the early 1980s gave insights into 
the DNA amplification at different stages of the parasite 
life cycle. In the mammalian host, DNA synthesis takes 
place when the parasite invades the hepatocytes  
(exo-erythrocytic schizogony) and during erythrocytic 
schizogony. In the anophiline host, parasite undergoes 
DNA replication during gametogenesis, once following 
fertilization prior to meiosis and during formation of 
sporozoites in oocysts9–12. One of the most interesting and 
unique features of DNA replication takes place during the 
activation of P. berghei microgamatocytes in the mos-
quito. Three successive rounds of DNA replication take 
place within 10 minutes raising the haploid nuclear content 
to octaploid level prior to exflagellation. This must be the 
highest rate of DNA replication observed in any known 
system. It is understood that the rate of DNA replication 
may not vary drastically among species9. Therefore, the 
usage of origins must be represented more frequently in 
this process. Erythrocytic schizogony is a relatively better 
characterized DNA replication event in the parasite life 
cycle, whereas others remain poorly understood. Timing 
and duration of DNA replication in synchronized parasite 
culture has been reported by different groups using  
radioactive nucleotides in the presence of DNA replica-
tion inhibitors like aphidicolin, hydroxyurea, etc.11. These 
results suggest that DNA replication initiates ~22–24 h 
following invasion, peaks at about 30–32 h and  
subsequently declines, continuing till 40–44 h post-
invasion. 
Replication initiation 
During initiation of replication, in all species, initiator 
proteins recognize the origin DNA. This is then followed 
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by the recruitment of additional proteins facilitating the 
localized unwinding of the origin DNA in preparation  
for DNA synthesis. It involves organization of a pre-
replicative complex (pre-RC) subsequently making way 
for the replication fork progression or elongation13. 
 However, despite some initial clues, the question of 
what events trigger initiation of replication is unresolved 
and largely unexplored. It is also still unclear how initia-
tion proteins mediate localized unwinding of DNA or 
how they recruit proteins involved in the elongation 
phase of replication. 
Origin of replication 
In eukaryotes, replication initiates in a coordinated man-
ner from multiple locations, termed origins of replication, 
distributed across each of the chromosomes14,15. These 
sequences do not exhibit much uniformity across eukar-
yotes. The problem of replicating DNA in a reasonable 
time appears to have been solved in two ways during evo-
lution, bacteria with rapid DNA synthesis rates can initi-
ate multiple temporally overlapping rounds of replication 
from a unique origin, whereas eukaryotes and some  
archaea have acquired multiple origins. In the unicellular 
eukaryote Saccharomyces cerevisiae, three to four  
sequences of 10–15 base pairs (bp) spread over 100–
150 bp consisting of highly conserved and essential A-
element or autonomously replicating sequence (ARS) 
consensus sequence (ACS) and less well-conserved ele-
ments called B elements are sufficient to act as an ori-
gin16,17. Unlike the conserved ACS, 20–50 bp, AT-rich 
sequences spread across 800–1000 bp aid the replication 
initiation in S. pombe18–20. These sequences do not show 
strong sequence similarity just like the origins of replica-
tion in higher eukaryotes which are spread over thou-
sands of base pairs and less well defined. For example, 
origins in early embryos of Xenopus laevis and Droso-
phila melanogaster do not exhibit any sequence specific-
ity to facilitate rapid DNA amplification17. 
 P. falciparum origin of replication is an unexplored ter-
ritory. Rapid rates of DNA amplification (schizogony)8,10 
have been observed at various stages of the life cycle and 
requirement of multiple origins firing appears inevitable. 
The parasite genome is highly AT-rich and propensity of 
AT-rich sequences to act as initiator sequences along 
with high rate of genome duplication may lead us to 
speculate that there may not be sequence specificity like 
origins in early embryos of X. laevis and D. melano-
gaster. To confirm whether the speculations are true or 
indeed there are consensus sequences which may initiate 
and direct DNA synthesis, calls for an immediate atten-
tion for mapping and characterizing such sequences with 
the aid of available genome sequence and relatively well-
characterized origin recognition complex (ORC) sub-
units.  
ORC subunits  
ORC, a six-protein complex, is one of the first molecules 
to arrive at the site of DNA replication initiation provid-
ing the landing pad for the subsequent components of 
pre-RC from yeast to mammals. ORC was first identified 
in S. cerevisiae, where it binds to the ACS21. 
 In P. falciparum, ORC1 was the first subunit of the 
ORC complex to be identified, initially reported only to 
be expressing predominantly in sexual erythrocytic stage22, 
but later established to be expressing in the asexual eryth-
rocytic stages as well23, substantiating a published mi-
croarray data24. PfORC1 (PFL0150w) shows 50% and 
53% homology with the S. cerevisiae and human ORC1 
proteins respectively. However, this homology is  
restricted to the C terminus only, whereas the long extended 
N-terminal harboured several aspargine and lysine re-
peats with little or no homology to any known ORC pro-
tein. The N-terminal contains a leucine heptad motif that 
might be involved in oligomerization and DNA-binding 
activity along with a putative nuclear localization signal 
(NLS) (Deshmukh and Dhar, unpublished data).  
 PfORC1 is expressed at the protein level exclusively in 
the nucleus during the late ring/early trophozoite stages, 
just at the beginning of the DNA replication25,26. More-
over, the purified C-terminal catalytic domain, PfORC1C 
with nucleotide binding and hydrolysis domains, showed 
ATPase activity. The ATPase activity of ORC1 is essential 
for origin activity in yeast, Drosophila, and Xenopus27–29. 
It has been further demonstrated that PfORC1 shows 
ATP-independent DNA-binding activity, which is con-
trary to yeast ORC23. PfORC1 may show nonspecific 
ATP-independent DNA binding in vitro, whereas ATP 
may play a major role in binding active origins in vivo. 
 Moreover, at the replicating trophozoite stage of the 
parasite life cycle, PfORC1 was seen to be colocalized 
with PfPCNA in distinct punctate nuclear foci, as visual-
ized by immunoflouresence microscopy. This result was 
further supported by direct physical interaction between 
PfORC1 and PfPCNA30, as shown by coimmunoprecipi-
tation of PfPCNA with PfORC1 from the replicating 
stage parasite. Interestingly, at late multinucleate schizont 
stage, nuclear PfORC1 staining disappeared and PfORC1 
was completely degraded25, in accordance with its stage-
specific protein expression profile that might serve an 
important role in the regulation of DNA replication. 
 Further, with the aid of yeast genetic complementation 
system, PfORC1 was demonstrated to harbour functional 
PCNA interacting protein motif (PIP) at its C-terminus, 
essential for cell viability as well as physical interaction 
between PfORC1 and PfPCNA30. Conserved residues in 
the PIP motifs of both ScORC1 and PfORC1 were muta-
ted and were subsequently tested for their ability to com-
plement the yeast ORC1 function. PIP mutant forms 
failed to complement yeast ORC1 function, suggesting its 
essential role in DNA replication30.  
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 Analysis of PlasmoDB also revealed31 the presence of 
an ORF (PFB0720c), which showed ~20% identity and 
~43% homology with the yeast ORC5 homologue at  
the carboxy-terminal region. This gene consisting of  
899 amino acid residues, has a long N-terminus exten- 
sion containing aspargine/aspartic acid/lysine-rich repeat 
regions similar to the PfORC1 subunit and is not an  
exceptional phenomenon for P. falciparum as reported 
earlier32.  
 This putative PfORC5 protein contains a functional 
NTP-binding domain at the N-terminus, a hallmark of 
ORC5 proteins25. Moreover, when tested for its ability to 
complement the yeast ORC5 mutant strain, the chimera 
construct carrying the C-terminus of PfORC5 fused with 
the N-terminus of ScORC5, was able to functionally 
complement the yeast mutant strain, whereas the full 
length or the N-terminus alone could not do so25. In vivo 
analysis of this protein using specific antibody against the 
parasite culture shows its distinct nuclear localization in 
clear punctate foci along with PfPCNA and PfORC1 at 
the replicating asexual stages25,30. These foci dissociated 
from each other at the late schizont stage. Moreover, for-
mation and progression of these replication stage foci 
were disrupted in the presence of hydroxyurea, a known 
replication inhibitor25, confirming the role of PfORC1 
and PfORC5 in parasite DNA replication.  
 A putative ORC2 ORF (MAL7P1.21) has been identi-
fied in the PlasmodB, which shares 36% and 42% homo-
logy with yeast and human counterparts respectively. 
Moreover, an unannotated ORF (Pf13_0189) sharing sig-
nificant homology to yeast and trypanosomatid ORC4 has 
been found (unpublished data). 
 P. falciparum genomic database failed to identify a dis-
tinct homologue of Cdc6. Cdc6 proteins are members of 
the AAA+ protein family (ATPases associated with vari-
ous cellular activities)33,34. In addition to the N-terminal 
AAA+ domain, Cdc6 proteins also contain a winged-
helix DNA-binding motif towards the C-terminus and are 
essential for eukaryotic DNA replication35. Interestingly, 
PfORC1 shares significant sequence homology with the 
human and yeast Cdc6/Cdc18 protein. The identity and 
similarity of PfORC1 with HsCdc6 was found to be 36% 
and 55%, respectively. Other members of the ORC  
family, namely ORC3 and ORC6 have not been found so 
far in P. falciparum. 
 The dynamic nature of ORC proteins has been high-
lighted by recent studies where ORC has been shown to 
be involved in functions other than its pivotal role of 
DNA replication initiation. ScORC has been implicated 
in transcriptional gene silencing, while in Drosophila, 
ORC2 is known to be associated with heterochromatin36–39. 
Similar studies with PfORC1 showed its involvement in 
telomere position effect (TPE) where ORC1 was found to 
be localized to distinct perinuclear sub-compartments of 
the nucleolus and telomere along with SIR2 protein of P. 
falciparum40. PfSir2 is a histone deacetylase41,42, that  
reversibly associates with the promoter regions of silent 
but not active subtelomeric var genes, which encode  
virulence genes of the parasite43–45. It seems that the  
N-terminal of PfORC1 has a specific role in parasite var 
gene silencing in coordination with PfSir2 (Deshmukh 
and Dhar, unpublished data). 
MCM2-7 helicase subunit 
The establishment of pre-RC requires recruitment of heli-
case ring which encircles the DNA, providing topologi-
cally stable interaction that allows efficient translocation 
and unwinding of DNA strands at the replication fork. 
The precise molecular mechanism of recruitment and un-
winding remains elusive. In eukaryotes, six different MCM 
(mini-chromosome maintenance) subunits (MCM2–7) are 
required for replication fork progression46. Similar to 
other eukaryotes, the Plasmodium genome encodes six 
MCM subunits. All six MCM subunits contain the signa-
ture MCM motif G(IVT)(LVAC)2(IVT)-D(DE)(FL) 
(DNST)KM along with a conserved WALKER A-type 
ATP-binding domain. In addition, a zinc-finger motif  
is located towards the N-terminus of MCM 2, 4, 6  
and 7, as would be expected for these MCM proteins47. 
Patterson et al.48 studied three out of these six subunits in 
the IE asexual cycle. The expression of these subunits 
shows a stage-specific pattern, peaking at the schizont 
stages with an increased localization in the nucleus at this 
stage. Interaction among these three MCM subunits was 
detectable in the ring and schizont stages of IDC. 
PfMCM6 was the only MCM among the three which  
remains bound to the chromatin throughout the asexual 
cycle48. 
 PfMCM4 shows 58–62% similarity and 38–41% identity 
with the MCM family of proteins across the conserved 
region (residues 203–995). It was initially reported to be 
present at the RNA level only in the sexual stage49, con-
firmed by proteome analysis data of sexual stage-specific 
parasite. However, subsequent studies revealed the pres-
ence of this protein in the nucleus during both asexual 
and sexual stages along with PfORC1, suggesting a func-
tional role for MCM proteins in parasite DNA replica-
tion50. PfMCM3 and 5 still need to be characterized in 
detail.  
 CDT1, a protein required for loading MCMs and gem-
inin that titrates CDT1 right at the beginning of the S 
phase to control re-initiation are yet to be identified  
and characterized in P. falciparum51–53. However, an  
unannotated ORF (PF13_237) having CDT1-like domain 
has been identified in the Plasmodium database. The  
absence of geminin is not surprising, as multiple rounds 
of DNA replication take place in the erythrocytic asexual 
stages. A model indicating the components of the pre-RC 
in eukaryotes and the corresponding proteins in Plasmo-
dium is shown in Figure 2. 
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Figure 2. Comparison of models of pre-replication complex formation in eukaryotes and Plasmodium. a, In eukaryotes, the pre-
RC complex formation involves an ordered assembly of a number of components: origin recognition complex (ORC) composed of 
six subunits (1–6), Cdc6, Cdt1 and MCM2-7. Origin sequences are conserved in yeast Saccharomyces cerevisiae, but not in higher 
eukaryotes. Two proteins kinases, CDK and DDK (Dbf4-dependent kinase) are required for the firing of licenced origins for initia-
tion. Activation by these kinases leads to changes in the pre-RC, causing the binding of Cdc-45 to the MCM complex. This results 
in an unwinding of replication origin. CDK activity may also be required for the phosphorylation of some pre-RC components 
leading to the inhibition of re-initiation. b, P. falciparum ORC contains ORC1/CDC6 and ORC5. ORC2 and ORC4 may also exist. 
PfPK5 is a homologue of P34cd2 cyclin-dependent kinase required for both entry into S-phase and mitosis in fission yeast cells, but 
the exact function in firing of licenced origins is unclear. The role of PfMrk and Mat1 in replication initiation is not known, but 
they phosphorylate replication proteins like MCM in vitro. A Cdt1-like protein is found in P. falciparum, although its function is 
not known. Other key regulators of pre-replication complex formation, DDK and Cdc45, appear to be absent in Plasmodium. The 
above model suggests that the malaria parasite may have a minimum pre-RC (adapted from Patterson, S. et al.48 and subsequently 
modified based on available data).  
 
Components of the replication complex at the 
fork 
After establishment of the pre-RC and onset of the sig-
nals marking the start of S phase of the cell cycle, further 
recruitment of several other proteins complete the build-
ing of mature DNA replication machines (‘replisomes’) 
for bidirectional DNA replication from each origin. The 
basic components of a replisome are the DNA replication 
fork itself, together with the primases, polymerases and 
processivity factors. Two classes of kinases, cyclin- 
dependent kinases and Dbf4-dependent kinases (DDK) 
have been known to be crucial at this point, primarily for 
the activation of the Pre-RC54. In P. falciparum, homo-
logues of these kinases are being looked into. Further 
discussion on plasmodial S-phase kinases would be done 
in a later section. 
 At this juncture another factor which needs to be men-
tioned is Cdc45. Initially identified in yeast55, Cdc45 is 
believed to play a crucial role in the transition of the pre-
RC into an active replication fork. It is known to be asso-
ciated with the MCM complex along with GINS (Go-Ichi-
Ni-San, i.e. 5-1-2-3) complex, activating the replicative 
helicases bringing about unwinding of the DNA double 
helix56–59. Although plasmodial homologue of Cdc45 has 
not yet been identified, it would be interesting to see if any 
other known replication protein undertakes its function. 
Primase 
Primase is the ssDNA-dependent RNA polymerase which 
is absolutely essential for chromosomal DNA replication 
as it catalyses de novo synthesis of discrete length oligo-
ribonucleotides (7–10 bp) that constitute the primers re-
quired for subsequent DNA synthesis by the polymerase 
alpha subunit60–62. Primase has the conserved features of 
the catalytic centres of DNA polymerases, RNA poly-
merases as well as that of reverse transcriptases. Origi-
nally, primase was identified as a heteroduplex, isolated 
as a part of DNA pol alpha complex63,64. 
 Pfprimase small subunit is encoded by an ORF of 1356 
nucleotides with a calculated molecular weight of 
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53 kDa. The study by Prasartkaew et al.65 has shown that 
the genomic sequence encoding Pfprimase is unusually 
interrupted by 15 introns. Amino acid sequence analysis 
of PfPrimase small subunit across eukaryotic species re-
vealed several conserved regions. Moreover, the features 
of the catalytic centre of DNA polymerase, reverse tran-
scriptase and RNA polymerase are shared by this parasite 
primase small subunit. Further, similarity with DNA  
polymerase alpha, RNA polymerase II and Herpes virus 
primase was identified at the C-terminal region. The pro-
tein purified from a recombinant baculovirus vector over-
expressed in Sf9 insect cells demonstrated its ability to 
initiate de novo primer formation65. In vivo expression 
pattern and localization of the protein has not yet been 
studied in detail.  
DNA polymerases 
One of the most important components of the replisome 
is the DNA polymerase that facilitates the incorporation 
of the correctly base paired deoxyribonucleoside mono-
phosphate onto a growing primer/template duplex, with 
the exception of some of the translesion polymerases66. 
Several different polymerases have been identified and 
characterized so far. They are categorized into five types, 
namely alpha (α), beta (β), gamma (γ), delta (δ) and epsilon 
(ε)66. DNA polymerase α, δ and ε are sensitive to aphidi-
colin, whereas DNA polymerase γ and β are resistant to 
aphidicolin, but sensitive to nucleotide analogues67–69. 
DNA polymerase β can be differentiated from DNA poly-
merase γ by its resistance to N-ethylmaleimide68,69. In  
addition, DNA polymerase γ is more processive than 
Polβ68–70. In P. falciparum asexual-stage parasite, several 
different polymerase activities have been reported71–78. 
The most recent being the study by Nunthawarasilp et 
al.75, which identified and partially purified a DNA po-
lymerase beta-like enzyme from large-scale P. falciparum 
parasite culture. This enzyme was found to be highly re-
sistant to aphidicolin and N-ethylmaleimide as in other 
eukaryotic enzymes, but was also resistant to 2,3-
dideoxythymidine-5-triphosphate and to other synthetic 
nucleoside analogues. Like other eukaryotic Polβ, this 
Polβ-like enzyme too showed possible involvement in 
base excision repair pathway67. Previously, in P. falcipa-
rum, DNA polymerase α had been purified and character-
ized from crude extract77, whereas DNA polymerase γ 
had been detected in both crude extract and parasite mi-
tochondrion78. The genes encoding P. falciparum DNA 
polymerases α and δ have been fully sequenced74,73. Polα 
shows an overall low (14–17%) amino acid sequence 
identity with Polα from other species, while PfPol δ 
shows very high degree of conservation when compared 
with Pol δ homologues from other eukaryotes. Horrocks et 
al.79 have probed the expression pattern of the two most 
important components of the replisome, that is, DNA 
Pol δ along with that of the processivity factor (PCNA) in 
the asexual erythrocytic phase. It shows that both the 
genes are expressed predominantly at the trophozoite/ 
schizont stage, both at transcript and protein level. Pro-
moter activity analysis of these two genes showed that the 
PCNA promoter was active throughout the asexual stage, 
whereas Pol δ promoter activity was only detectable at 
the trophozoite stage.  
Processivity factors 
Isolated polymerases have a low affinity for DNA, result-
ing in frequent dissociation during synthesis. To increase 
processivity within the replisome, the polymerase is cou-
pled to a specialized sliding clamp that encircles DNA, 
but does not bind tightly to it, and effectively tethers  
polymerase to the DNA. The two sliding clamps at each 
replication fork are positioned behind the polymerases on 
each strand, such that they encircle the newly formed 
double-stranded DNA (dsDNA). PCNA aids in a range of 
DNA-processing events80,81. All of the PCNA-interacting  
factors were found to contain short, highly conserved  
sequence motifs (PCNA interacting protein motif, PIP) 
that were important for the interactions82–84. PCNA was 
first identified by Miyachi et al.85 in 1978 and later Bravo 
and Celis86 characterized it and called it ‘cyclin’. The 
PCNA/cyclin was directly implicated in DNA replication 
using SV40 in vitro replication system87 and was demon-
strated to be an auxiliary factor for DNA pol delta88,89. 
Using SV40 in vitro replication system, it has been 
shown that PCNA associates with replication factor C 
(RF-C) and ATP at the 3′ OH terminus of the first  
Okazaki fragment to be synthesized from the origin, thus  
facilitating a switch from alpha polymerase to delta  
polymerase-mediated DNA synthesis90,91. 
 P. falciparum, unlike most eukaryotes, harbours two 
PCNAs. Certain organisms, including the thermoacidophilic 
archaeon Sulfolobus solfataricus92, Aeropyrum pernix93, the 
chlorella virus Paramecium bursaria94,95, the carrot plant 
Daucus carota96, the maize plant Zea mays97,98, the plant 
Arabidopsis thaliana99,100 and the fellow protozoan 
Toxoplasma gondii101 also contain multiple PCNAs. 
 The first PCNA (PfPCNA1) identified in P. falciparum 
was encoded by chromosome 13, consisting approxi-
mately 270 amino acids with a predicted molecular mass 
of 30.168 kDa and shared an overall identity of 34% and 
31% with human and yeast PCNA respectively102. It con-
tained all the conserved residues of a processivity factor. 
PfPCNA1 was demonstrated to be expressing predomi-
nantly at the late trophozoite and schizont stages coincid-
ing with the expression of polymerase delta79. More 
recently, PfPCNA1 was demonstrated to form distinct 
nuclear punctate foci co-localizing with subunits of origin 
recognition complex (1 and 5) during replicating tropho-
zoite stages of the asexual cycle25. PfPCNA1 was also 
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shown to functionally interact with PfORC1 most likely 
through its PIP motif30. Together these data support the 
involvement of PfPCNA1 in DNA replication in the 
asexual erythrocytic stage. Additionally, PfPCNA1 has 
been studied as a model to understand the temporal con-
trol of genes during P. falciparum asexual stages103. Pre-
vious studies also characterized the minimal promoter 
(including mapping of the transcription start site) and 
demonstrated (using a transient transfection system) a 
role for flanking sequences in directing the absolute level 
of gene expression79 of PfPCNA1. 
 Later, two groups independently reported the identifica-
tion of a second PCNA in the P. falciparum genome104,105. 
PfPCNA2 located on chromosome 12, codes for a protein 
of 264 amino acids with a predicted molecular weight of 
30.2 kDa. It shares an overall similarity of 43–56% with 
other members of the PCNA family and a 29% identity 
with PfPCNA1. Molecular modelling studies based on 
structures of human and yeast PCNA suggest that 
PfPCNA2 may form a trimeric ring with a six-fold axis of 
symmetry106,107. Northern blot analyses revealed two 
transcripts with size of 1800 and 2500 nucleotides respec-
tively. The former is expressed in both asexual and sexual 
stages, whereas the latter is specifically expressed in the 
sexual stage, suggesting that PfPCNA2 may play an  
essential role in DNA metabolism at different stages of 
the parasite. 
Replication factor complex 
During DNA replication in vivo, the sliding clamp  
requires a specialized clamp loader complex to open and 
shut the ring around dsDNA whenever DNA synthesis is 
initiated at a primer. Since lagging strand synthesis re-
quires frequent reloading of the polymerase and sliding 
clamp, the clamp loader complex is an integral compo-
nent of the replisome108. The loading of PCNA onto DNA 
by the replication factor complex (RFC) is an important 
step in DNA replication and increases the processivity of 
DNA polymerase109. 
 Most RFCs are composed of five subunits highly con-
served in all eukaryotes. Plasmodium genome mining has 
identified an RFC5 (PF11 0117) homologue that displays 
an overall sequence similarity of 30% to replication fac-
tor complex subunits from Drosophila and yeast. RFC5 
contains: (i) the Walker A nucleotide-binding motif (con-
sensus sequence, GxxGxGKS/T) encompassing residues 
40–47, (ii) the Walker B nucleotide hydrolysis motif con-
sensus containing four aliphatic residues followed by two 
negatively-charged residues, encompassing residues 128–
133, and (iii) an arginine finger. The arginine finger is an 
AAA+-family specific motif that senses ATP-binding and 
hydrolysis, and transmits conformational changes110. The 
RFC clamp loader has been shown to require the arginine 
finger sensors (emanating from each of the subunits) to 
drive DNA binding and loading of the PCNA111. In vivo 
expression profiling reveals that PfRFC5 peaks in late 
trophozoites through early schizont stages, where most of 
the DNA replication is thought to occur24. 
 PfRFC5 has been identified along with another pre-RC 
protein, PfMCM6, to be interacting with CDK Pfmrk in a 
bacterial two-hybrid screen. Pfmrk was found to phos-
phorylate both PfRFC-5 and PfMCM6 in vitro112. Like 
other eukaryotes, whether their phosphorylation status af-
fects their subcellular localization and their ability to bind 
DNA and other subunits requires further studies113–145. 
Replication protein A  
Replication protein A (RPA) is a eukaryotic, single-
stranded (ss) DNA-binding protein which plays essential 
roles in various aspects of DNA metabolism, including 
replication, recombination and repair116. The protein has 
much higher propensity to bind ssDNA117–119 than towards 
dsDNA and RNA120,121. Eukaryotic RPA exists as a het-
erotrimeric complex and consists of subunits of size 70, 34 
and 14 kDa respectively. 
 P. falciparum replication protein A large subunit 
(PfRPA1) was isolated and identified in the parasite  
extract through affinity purification and mass spectral 
analysis. A 55 kDa factor displaying a major single-
strand binding activity was identified from the parasite 
extract. Subsequent sequence analysis revealed homology 
varying from ~ 34% to 39% with other eukaryotic RPA 
large subunits, but restricted only to the C-terminal 466 
amino acids. Interestingly, the large RPA subunits in 
higher eukaryotes have molecular masses ranging between 
67 and 73 kDa, while PfRPA1 similar to large RPA sub-
units identified in fellow protozoan Cryptosporidium 
parvum122 and Crithidia fasciculata123 has molecular 
mass between 51 and 55 kDa. This has been attributed to 
the absence of a N-terminal protein interaction domain 
found in all other RPA large subunits. PfRPA1 located on 
chromosome 4 (GenBank™ accession number AL035475) 
is encoded by an unusual 6.5 Kb transcript, indicating the 
presence of extensive 5′ and 3′ untranslated regions. Pro-
tein expression profile of PfRPA1 in IE asexual stages 
coincides with the replication phase in late trophozoites 
and schizonts124, which is in agreement with the expres-
sion profile of other DNA replication genes. Other sub-
units of this heterotrimeric complex in P. falciparum are 
still to be identified and characterized. 
Topoisomerases 
Topoisomerases are critical because of their ability to  
relieve torsional stress and resolve topological constraints 
arising as a by-product of DNA metabolism. They are 
termed as type-I if one strand of the dulpex DNA is 
cleaved, whereas the type-II class cleaves both the 
strands125,126. 
SPECIAL SECTION: MALARIA RESEARCH 
 
CURRENT SCIENCE, VOL. 102, NO. 5, 10 MARCH 2012 732 
 Studies with SV40 cell-free system shows that either of 
the Topos (I or II) is sufficient for DNA replication, 
whereas Topo II is required for daughter molecule de-
catenation in yeast127. While Topo I has been shown to be 
involved in gene transcription in yeast128 and Droso-
phila129. Topo II has been reported to be present in high 
levels in rapidly dividing cells130,131, and a number of 
anti-cancer drugs are known which act as Topo II poi-
sons126. Moreover, Topo II plays a critical role at the cen-
tromeres during mitosis and has also been implicated in 
efficient chromosomal segregation across species132,133. 
 P. falciparum homologue of Topo II was identified by 
Cheesman et al.134. Sequence analysis revealed an overall 
identity of 47.4% and a similarity of 65.4% with human 
Topo II, whereas with S. cerevisiae homologue, 44.4% 
identity and 62.2% similarity is shared indicating a rela-
tively higher degree of conservation compared to other  
P. falciparum replication factors. The degree of conserva-
tion is generally greater in the amino terminal two-thirds 
of the coding sequences and falls off markedly towards 
the carboxy-termini. A study showed the presence of  
Topo II throughout the IE cycle by immunofluorescence 
analysis using specific antibodies134. Any direct correla-
tion of PfTopo II expression with DNA replication is still 
awaited. 
FEN-1 
Flap endonuclease-1 (FEN-1) is a divalent, cation-depen-
dent, dual-function nuclease operating as a 5′–3′ exonu-
clease in the processing of Okazaki fragments during 
lagging-strand DNA synthesis and a structure-specific 
endonuclease involved in long patch BER135,136. FEN-1 is 
responsible for general genomic maintenance, and loss of 
FEN-1 has resulted in increased trinucleotide repeat  
expansion, destabilization of telomeres and general  
genomic instability137–140. Previously it has been demon-
strated that P. falciparum repairs AP sites in DNA pre-
dominantly via long-patch base excision repair (BER) 
where the damaged DNA strand is displaced by a DNA 
polymerase. As ~10–12 nucleotide repair patch is synthe-
sized, a ssDNA flap is generated, and subsequently acted 
upon by FEN-1 to endonucleolytically resolve the DNA 
flap. As a result, a single-stranded nick is created that can 
be ligated by DNA ligase I141. In contrast, mammalian 
cells show preference for short-patch repair pathway, re-
ferring to the fewer nucleotides length of the repair patch. 
Moreover, most of the components required in the long-
patch pathway could be identified in the Plasmodium  
genomic database. Casta et al.142, first identified PfFenI 
which was localized to chromosome 4, encoding 2019 bp 
long gene, weighing 76.6 kDa. The study reported that 
PfFEN1 has enzymatic activities similar to other species, 
but contains extended C-termini and a more internally lo-
cated PCNA-binding site, while its N-terminus domain 
and intermediate domain show high degree of conserva-
tion143–145. In this study, PfFEN1 along with murine FenI 
was demonstrated to possess DNA structure-specific flap 
endonuclease and 5′–3′ exonuclease activities, similar to 
FEN1s from other species. Additionally, endonuclease 
activity was stimulated by Mg2+ or Mn2+ and inhibited by 
monovalent ions (>20.0 mM). Interestingly, a PfFEN1 C-
terminal truncation mutant lacking the terminal 250 
amino acids had endonuclease activity that was ~130-fold 
greater than full-length PfFEN1 in vitro142. Also PfFEN1 
generated a nicked DNA substrate that was ligated by  
recombinant Pf DNA ligase I (PfLigI)146 using an in vitro 
DNA repair synthesis assay. This study suggests PfFenI 
as a critical component of both DNA replication and  
repair machinery, although further in vivo studies are  
required to substantiate these claims. 
DNA ligase I 
DNA ligase I constitutes the primary ligase utilized in 
DNA replication within the eukaryotic nucleus by joining 
the Okazaki fragments, and plays a critical role in DNA 
repair and recombination by nick sealing during long-
patch BER. Many eukaryotes express three DNA ligase 
isoforms, DNA ligase I, III and IV. DNA ligase III, asso-
ciated only with vertebrate cells is also involved with 
DNA repair in the nucleus and mitochondria147. DNA ligase 
IV has been identified in lower eukaryotes such as yeast 
and is involved in repairing DNA double-strand breaks as 
well as V(D)J recombination and non-homologous end-
joining (NHEJ)148. Ligase I knockouts are lethal in 
mice149, while its overexpression has been linked to vari-
ous human cancers and induced genetic instability in 
yeast150,151. 
 Buguliskis et al.146 identified and characterized codon-
optimized recombinant PfLigI. This is localized to chro-
mosome 13 and is a 2.7 kb gene encoding a 912 amino 
acid protein with a probable molecular weight of 104 kDa. 
It showed a 30% overall sequence identity to human 
DNA ligase I and 60% identity in the C-terminal region. 
Curiously missing from the N-terminus of PfLigI is a 
PCNA binding domain, which is replaced by a putative 
apicoplast targeting signal. The kinetic parameters of 
PfLigI are similar to other eukaryotic ATP-dependent 
DNA ligases and displays a divalent metal cofactor  
dependence. All the replication proteins as described above 
and their status in P. falciparum are shown in Table 1. 
Cyclin-dependent kinase-like proteins in  
P. falciparum  
The regulation of DNA replication by cell cycle-regulated 
kinases (cyclin-dependent kinases, CDKs) and their regu-
latory counterparts has been established in eukaryotes152. 
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Table 1. Details of proteins involved in nuclear DNA replication 
Protein  PLASMODB No. Reference 
 
Origin recognition complex1 (ORC1) PFL0150w 23, 25, 30 
Origin recognition complex5 (ORC5) PFB0720c 25 
Origin recognition complex2 (ORC2) MAL7P1.21 – 
Origin recognition complex4 (ORC4) PF13_0189 – 
Mini-chromosome maintenance (MCM) proteins  PFE1345c, PF07_0023, 48–50 
  PFL0580w, Pf13_0095, 
  PF13_0291, Pf14_0177  
CDT1 PF13_0237 – 
Replication protein A (RPA) large subunit PFD0470c 124 
Replication factor C (RFC) PFA0545c 24, 112 
Proliferating cell nuclear antigen 1 (PCNA1) Pf13_0328 47, 49, 50 
Proliferating cell nuclear antigen 2 (PCNA2) PFL1285c 104–107 
Primase PF14_0366 65 
DNA polymerase alpha PFD0590c 74, 77 
DNA polymerase epsilon PFF1470c – 
DNA polymerase delta PF10_0165 73, 79 
DNA polymerase beta ? 75 
FLAP endonuclease-I (FenI) PFD0420c 142–146 
DNA ligase I MAL13P1.22 146 
Topoisomerase II PF14_0316 134 
 
 
Bioinformatic analysis indicated the presence of several 
CDK-like kinases and their effectors in P. falciparum, 
and their biochemical characterization is being done153–155. 
Among these kinases, the most prominent ones are 
Pfmrk, PfPK5 and PfPK6156–159. 
 Pfmrk shows 46% homology to human CDK7. This 
protein along with its effector PfMAT1 phosphorylated 
two components (namely PfRFC5 and PfMCM6) of the 
replication fork as its substrate in vitro112. Although the 
in vivo phosphorylation status of these DNA replication 
components remains to be investigated, it is possible that 
Pfmrk-mediated phosphorylation of the above proteins 
may regulate the initiation of DNA replication112. Another 
malarial CDK-like kinase, PfPK5, has been proposed to 
play a role in DNA replication155,157. PfPK5 expression 
and kinase activity levels peak 36 h post-invasion and 
PfPK5 has been shown to co-localize with DNA in the 
early trophozoite stages or just at the onset of DNA syn-
thesis. Elevated PfPK5-associated kinase activity was  
detected in parasites treated with the DNA synthesis  
inhibitor aphidicolin, whereas treatment of the parasite 
with the PfPK5 inhibitors flavopiridol and olomoucine  
resulted in reduced DNA synthesis158. 
 Analysis of the amino acid sequences of few of the  
replication proteins like PfORC1 revealed the presence of 
conserved CDK-like consensus sequence25 (SPTK and 
TPKK) at the N-terminus (Deshmukh and Dhar, unpub-
lished data). Further, preliminary results indicate phos-
phorylation of PfORC1 at the late trophozoite/schizont 
stage followed by its degradation at the very late schizont 
stage just before the release of the merozoites25 
(Deshmukh and Dhar, unpublished data). It will be inter-
esting to see whether Plasmodium CDK-like kinases are re-
sponsible for PfORC1 phosphorylation and its regulation. 
 Few Plasmodium cyclin-like proteins have been char-
acterized in vitro160. Their putative role in Plasmodium 
DNA replication in vivo needs to be studied further.  
A model for Plasmodium DNA replication and 
overall cell cycle progression during the IE stage 
Endoreduplication is a process that takes place during dif-
ferentiation of mammalian trophoblasts and megakaryo-
blasts161. This process is a manifestation of rapid DNA 
replication where re-initiation may take place before the 
end of one replication cycle. Considering the rapid DNA 
replication during erythrocytic trophozoite stage where 
1N may give rise to 16N to 32N nuclear content, it is 
possible that P. falciparum undergoes endoreduplication, 
although it needs to be verified experimentally. 
 The duration of DNA replication and mitotic phases in 
P. falciparum IE stages is not clearly defined. Recent 
studies157 demonstrated the asynchronous division of cen-
triolar plaques (CPs), eukaryotic equivalent of centrosomes 
and correlated its significance with mitotic progression. 
There is still speculation over the cell-cycle phases of the 
parasite IE stage, specifically surrounding the timing of 
nuclear envelope division following genomic divi-
sion25,162,163. An accurate model of P. falciparum IE cell-
division cycle requires detailed analysis of events and 
timings of mitotic progression. 
 There is a cyclic pattern in the expression of most of 
the characterized core replication proteins in the IE  
asexual cycle, where there is distinct upregulation in the  
expression in the mid/late trophozoite to early schizont 
stages coinciding with the active replication window. 
This is demonstrated by the foci dynamics study involv-
SPECIAL SECTION: MALARIA RESEARCH 
 
CURRENT SCIENCE, VOL. 102, NO. 5, 10 MARCH 2012 734 
ing ORC subunits (1 and 5) along with PCNA125. Based 
on the above observations along with other published 
data, we propose a simplified model of cell-cycle pro-
gression of IE schizogony (Figure 3) whereby the ring 
and early trophozoite stage (0–18 h PI) carrying a single 
nucleus could be representative of the G1 phase, while 
the onset of the synthetic phase (S-phase) is marked by 
the assembly of ORC proteins (subunits 1 and 5) in dis-
tinct nuclear foci along with the marker of active DNA 
replication PCNA1. This model suggests that the S-phase 
(18–36 h PI) may be characterized by coordinated proc-
essing of clustered replication forks and as we move to-
wards the end of this phase, the foci disassemble and 
fulfil their independent fates as demonstrated by dissocia-
tion of ORC (1 and 5) and PCNA1 foci and subsequent 
degradation of ORC1 at the late schizont stage. The deg-
radation of ORC1 may involve phosphorylation by CDK-
like kinase, PfPK5. This is followed by a post-replicative 
phase, including completion of chromosome segregation, 
cytokinesis and formation of daughter nuclei (mero-
zoites), which may be representative of the G2/M phase. 
Invasion of fresh RBCs by these newly formed merozoites 
marks the beginning of the next cycle. It is important 
 
 
 
 
Figure 3. Model of replication foci formation and progression in P. 
falciparum. Plasmodium ORC consists of ORC1, ORC5 and putative 
ORC2 and ORC4 subunits. During intraerythrocytic developmental cy-
cle (IDC), ORC1 is expressed at the late-ring stage, whereas PCNA1 
and ORC5 are present through all stages. At the onset of DNA replica-
tion, during early trophozoite stage, these proteins co-localize with 
each other and form replication foci. These foci persists till the late 
trphozoite/early schizont stage. During late schizont stage, ORC5 and 
PCNA1 slowly dissociate from each other. However, ORC1 is com-
pletely degraded at the late schizont stage possibly via phosphorylation 
mediated by PfPK5 (unpublished data). G1, S and G2/M phases are  
indicated according to parasite developmental stages. There may be 
considerable overlap between different stages, especially between the S 
and G2/M phase, which is not indicated in the model. This model  
suggests a critical role for PfORC1 in the regulation of parasite DNA 
replication (adapted from Gupta, A. et al.25 and subsequently modified 
based on available data).  
to note that there may be certain overlap between the  
S phase and G2/M phase as segregation of chromosome 
and nuclear division take place along with the DNA  
replication, which is contrary to the eukaryotic systems  
in general.  
Organelle DNA replication  
The phylum Apicomplexa which includes the malaria 
parasites, contains two organelles containing extrachro-
mosomal DNA: mitochondria (mtDNA) and plastid-like 
apicoplast (plDNA). 
 Mitochondria are essential organelles required for  
energy transduction and cellular functions, and are ubi-
quitous in almost all eukaryotic cells. Like nuclear genome, 
mitochondrial (mt) genome exhibits remarkable variation 
in structure and size164. The largest mt genome is found 
in land plants165, in which the size ranges from 180 to 
2400 kb. The Plasmodium mt genome has the smallest, 
multi-copy, linear and tandemly repeated 6-kb element166. 
The mitochondrial genome is highly conserved among 
Plasmodium species167. The genome of mitochondria has 
a concatemeric structure168 present in S. cerevisiae and 
other fungi169,170. The Plasmodium mt genome encodes 
only three protein-coding genes: cytochrome c oxidase 
subunit I (coxI), coxIII and cytochrome b (cob). It also 
contains large- and small-subunit ribosomal RNA (rRNA) 
genes, which are highly fragmented171. The apicoplast is 
believed to be the site for type-II fatty-acid biosynthe-
sis172,173, the non-mevalonate pathway of isoprenoid  
biosynthesis174,175, as well as synthesis of heme-
intermediates within the parasite176. The apicoplast contains 
a ~35 kb, closed, circular, dsDNA genome of unusually 
high A/T content (86%) that carries genes for large- and 
small-subunit rRNAs and accompanying ribosomal pro-
teins, 25 species of tRNA, an RNA polymerase and sev-
eral ORFs coding for chaperones as well as other proteins 
of unknown function177. 
 The timing of replication of both plDNA and mtDNA 
in blood-stage cultures is well established. It is known 
that total DNA synthesis starts in trophozoite and contin-
ues into schizogony9,10,12,178,179. Both organelle DNAs 
start replicating at about the same time, a few hours  
before the first nuclear division that marks the onset of 
schizogony180,181. Each sporozoan cell of the parasite car-
ries a single apicoplast182,183 with estimated copy number 
of plDNA varying from 1 to 15. 
 The plDNA is replicated by a bidirectional theta 
mechanism and segregated into daughter cells184–188. The 
mtDNA replication involves both a rolling circle mecha-
nism and a recombination-associated process resembling 
that of bacteriophage T4178,186,187. 
 The replication of plDNA initiates within the inverted 
repeat (IR) region that covers a ~10 kb segment and car-
ries genes for large- and small-subunit rRNA and several
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Table 2. Details of proteins involved in organelle DNA replication 
Protein PLASMODB No. Organelle Reference 
 
Gyrase A PFL1120c Apicoplast 193 
Gyrase B PFL1915w Apicoplast 192, 193 
Single-strand DNA-binding (SSB) protein  PFE0435c Apicoplast 194 
Topoisomerase VI MAL13P1.328 Apicoplast – 
Plastid replication–repair enzyme PF14_0112 Apicoplast 195, 196 
Topoisomerase IV Pf10_0412 Apicoplast – 
Apicoplast genome replication DNA polymerase Pfprex PF14_0112 Apicoplast 195, 196 
 (primase, helicase and exonuclease/polymerase)  
 
 
tRNAs188–190. The plDNA replication proceeds via two 
mechanisms. The first one follows the theta mode with 
replication initiating within the IR region, while a minor 
population of plDNA molecules may follow the rolling 
circle mode possibly utilizing as yet unidentified initia-
tion sites outside the IR. The multiple ori within each IR 
sector have been identified and differential utilization of 
these initiation sites during plDNA replication has been 
suggested190. The biochemical and cellular processes  
involved in plDNA replication are poorly understood. 
The apicoplast genome itself does not encode any pro-
teins known to be involved in DNA replication. However, 
several proteins that are involved in apicoplast DNA 
metabolic processes are encoded by the nuclear genome, 
synthesized in the cytoplasm and transported to the  
apicoplast. These include bacteria-like gyrase, ssDNA-
binding (SSB) protein, apicoplast genome replication 
DNA polymerase, Pfprex and several unclassified ORFs 
that are homologous to DNA repair enzymes191–195. 
Pfprex is a large (2016 aa), multifunctional peptide that 
contains three distinct domains that exhibit DNA pri-
mase, DNA helicase and DNA polymerase activities re-
spectively195,196. The KPom1 (Klenow-like polymerase of 
malaria 1) DNA polymerase domain of Pfprex exhibits a 
strongly biased mutational spectrum, and differs signifi-
cantly196 from the closely related Escherichia coli DNA 
polymerase I. Table 2 shows the list of proteins involved 
in apicoplast DNA replication. 
 This description has underlined our limited understand-
ing of the replication of organelle DNAs in the malaria 
parasites and there is a clear need for progress on both the 
regulation and enzymology of the process(es) in each of 
the apicomplexan organelles. Apart from any intrinsic 
value, knowledge of the genes involved in mediating  
organellar DNA replication is doubly valuable. The essen-
tially prokaryotic nature of the two organellar compart-
ments suggests that they offer potential as drug targets. 
Concluding remarks  
While some progress has been made in identification and 
characterization of individual P. falciparum DNA replica-
tion proteins, it is clear that considerable challenges lie 
ahead. Both replication initiation and replication fork  
assemblies are complex nucleoprotein machines, with 
highly defined architectures and regulation. Efforts must 
now be made for the molecular dissection of these fun-
damentally important and conserved processes in one of 
the most important human pathogens. 
 Moreover, there are different stages in the complex life 
cycle of the parasite where DNA replication takes place10 
for which there is little or no information available. Al-
though it is beyond the scope of this review which pri-
marily focuses on the IE stage, it is imperative to mention 
the need and the importance of probing the DNA replica-
tion event in the other stages of the P. falciparum life cycle. 
 Unprecedented success of this parasite in adapting to 
challenges of the host environment like immune pressure 
and antimalarial drugs may be due to the dynamic nature 
of its DNA metabolism. In spite of the overall conserva-
tion in the DNA replication machinery, there are certain 
peculiarities unique to the parasite which may be used to 
evaluate the possibility of using the replication apparatus 
as a drug target for malaria therapy. Efforts are already 
being channelized in this regard. Topoisomerase II poi-
sons have been evaluated as antimalarial agents. In this 
regard, 9-anilinoacridines, which are structurally related 
to pyronaridine have been extensively studied197,198. 
 The other important aspect is that many of the replica-
tion proteins contain long N-terminal extension with no 
homology with their host counterparts. The members of 
the origin recognition complex (namely ORC1 and 
ORC5) are worth mentioning in this regard. Some of 
them also contain important motifs or signatures that can 
be used as potential targets against malaria therapy. As 
DNA replication is central to the parasite proliferation 
and pathogenesis, continuous efforts to combat these 
processes will be helpful amidst the growing incidences 
of drug resistance and lack of an effective vaccine. 
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